Moffitt Treating Brain Lesions With New Visualase Laser Technology

Where You Are:

VISUALASE MRI-GUIDED LASER ABLATION FOR MINIMALLY INVASIVE NEUROSURGERY

VisualaseMoffitt Cancer Center is now treating brain lesions with Visualase — a new technology that uses laser ablation to destroy tumors found in soft tissue in the brain. Surgery can also be difficult and risky due to proximity to critical structures, and radiation therapy can damage healthy tissue. Visualase is a new technology that uses light energy to destroy soft tissue, including tumor or damaged tissue. Energy is delivered through a laser probe, causing temperatures in the target area to rise and unwanted tissue to be destroyed. Because Visualase is guided by MRI images, the procedure can provide precise targeting. And, according to medical journals, it has been reported to be pain-free and require a short recovery time. Other advantages of Visualase include: 

  • Can be performed with patient wide awake
  • Requires no radiation or skull flap
  • Usually requires only a one-day hospital stay
  • Does not limit use of other treatment options
  • Often performed on otherwise inoperable tumors/lesions

DR. ARNOLD B. ETAME, MD, PhD

EtameArnold_11367.jpgUsing the Visualase technology at Moffitt is Dr. Arnold B. Etame, attending Neurosurgeon, Scientist and Assistant Professor of Oncological Sciences at USF College of Medicine. Dr. Etame is advancing state-of-the-art care utilizing and engineering best practices for the treatment of brain and spinal tumors, and his belief in personal care for patients and families allows for the best possible outcomes.

More on our approach to treating brain cancer

Learn more about what differentiates Moffitt by visiting MOFFITT.org/MD

 

 
 
 
TOOLS:   Font Size small font resizer separator font resizer separator big font resizer
 |  Site Map  |  Privacy Policy  |  Terms and Conditions